GenoLogics Pockets $5M in VC Funding to Accelerate Sales, Product Development | GenomeWeb

Proteomics software startup GenoLogics last week closed a $5 million Series A financing round led by OVP Venture Partners of Seattle and Yaletown Venture Partners of Vancouver. Working Opportunity Fund, managed by Growth Works Capital of Vancouver, also participated in the round.

The company, based in Victoria, British Columbia, will spend the cash more or less evenly between expanding its sales and marketing operations and its product-development activities, CEO Michael Ball told BioInform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.